切换至 "中华医学电子期刊资源库"

中华腔镜泌尿外科杂志(电子版) ›› 2019, Vol. 13 ›› Issue (01) : 40 -44. doi: 10.3877/cma.j.issn.1674-3253.2019.01.010

所属专题: 文献

临床研究

泌尿系统围手术期多重耐药菌感染的临床分析
康厚彬1,(), 何秉勋1, 艾航宇1, 朱智虎1, 薛斌1   
  1. 1. 615000 四川,凉山州第二人民医院泌尿外科
  • 收稿日期:2017-12-07 出版日期:2019-02-01
  • 通信作者: 康厚彬

Clinical analysis on multidrug-resistant organism infection of urinary system during perioperative period

Houbin Kang1,(), Bingxun He1, Hangyu Ai1, Zhihu Zhu1, Bin Xue1   

  1. 1. Department of Urology, the Second People's Hospital of Liangshan, Xichang, Sichuan 615000, China
  • Received:2017-12-07 Published:2019-02-01
  • Corresponding author: Houbin Kang
  • About author:
    Corresponding author: Kang Houbin, Email:
引用本文:

康厚彬, 何秉勋, 艾航宇, 朱智虎, 薛斌. 泌尿系统围手术期多重耐药菌感染的临床分析[J]. 中华腔镜泌尿外科杂志(电子版), 2019, 13(01): 40-44.

Houbin Kang, Bingxun He, Hangyu Ai, Zhihu Zhu, Bin Xue. Clinical analysis on multidrug-resistant organism infection of urinary system during perioperative period[J]. Chinese Journal of Endourology(Electronic Edition), 2019, 13(01): 40-44.

目的

分析围手术期泌尿系统多重耐药菌感染的尿细菌谱及其药物敏感实验结果,指导临床治疗。

方法

回顾性分析我院自2013年1月至2016年12月154例患者围手术期清洁中段尿培养的多重耐药感染细菌谱和药物敏感实验结果报告。

结果

154例多重耐药菌感染患者中革兰氏阴性菌有148例,占96.1%(148/154),阴性菌中β-内酰胺酶(ESBLs)阳性145例,占97.97%(145/148),阴性中大肠埃希菌127例,占第一位为82.47%(127/154),其中ESBLs阳性125例,占98.43%(125/127);革兰氏阳性菌有6例,其中屎肠球菌4例,溶血葡萄球菌2例。多重耐药菌在疾病分布中泌尿系结石占69.48%(107/154),其次为泌尿系梗阻占21.43%(33/154);人群分布中以中老年组最多,占80.52%(124/154),青年组占15.58%(24/154)。对革兰氏阴性菌耐药率高的抗菌药分别是:羧苄西林、环丙沙星、头孢噻肟、复方新诺明,而敏感率较高的药物为:亚胺培南、阿米卡星、哌拉西林/他唑巴坦、呋喃妥因;革兰氏阳性菌敏感率高抗菌药为:亚胺培南、万古霉素,耐药率较高的药物为:羧苄西林、环丙沙星、头孢噻肟、复方新诺明、头孢他啶。

结论

围手术期尿路多重耐药菌感染患者中以革兰氏阴性菌感染为主,其中又以大肠埃希菌最多,产生耐药性的主要原因为产生ESBLs。在进行经验性治疗时可选择对大肠埃希菌产ESBLs菌株敏感的抗菌药物进行治疗,并加强对抗菌药物使用的监测。

Objective

To analyze the urinary bacterial spectrum and drug sensitivity test results of multidrug resistant bacterial infection in the urinary system during the perioperative period, aiming to guide clinical treatment.

Methods

The multidrug resistant bacterial spectrum and drug sensitivity test results of 154 patients with multidrug-resistant infection in the urine culture during the perioperative period in our hospital from January, 2013 to December, 2016 were retrospectively analyzed.

Results

Among 154 cases, 148 patients were infected with Gram-negative bacteria (96.1%, 148/154) including positive ESBLs in 145 cases (97.97%, 145/148) and Escherichia coli in 127 patients (82.47%, 127/154), which included positive ESBLs in 125 cases (98.43%, 125/127). Six cases were infected with Gram-positive bacteria, including 4 cases of Enterococcus faecium and 2 cases of Staphylococcus haemolyticus. Multidrug-resistant bacteria were dominantly detected in urinary stones, accounting for 69.48% (107/154), followed by urinary obstruction (21.43%, 33/154). Regarding the population distribution, the middle-aged and elderly patients accounted for 80.52% (124/154) and 15.58% (24/154) for their young counterparts. Antibiotics with high resistance to Gram-negative bacteria included carboxybenzillin, ciprofloxacin, cefotaxime and compound sulfamethoxazole, whereas those with high sensitivity consisted of imipenem, amikacin, piperacillin/tazobactam and nitrofurantoin. Antibiotics with high sensitivity to Gram-positive bacteria were imipenem and vancomycin, and those with high resistance included carboxybenzillin, ciprofloxacin, cefotaxime, compound sulfamethoxazole and ceftazidime.

Conclusions

Gram-negative bacteria are the main cause of infection in patients with multidrug-resistant bacterial infection in the urinary tract during perioperative period, dominated by the Escherichia coli. The main cause of drug resistance is the generation of ESBLs. During empirical treatment, antibiotics sensitive to the ESBLs of Escherichia coli can be selected. The monitoring of antibiotic use should be strengthened.

表1 泌尿系多重耐药菌感染各年龄段分布
表2 泌尿系多重耐药菌感染基础疾病分布
表3 泌尿系多重耐药菌感染病菌分布结果
表4 泌尿系统多重耐药菌耐药率分布结果(%)
[1]
Flannigan R, Choy WH, Chew B, et al. Renalstruvitestones-pathogenesis, microbiology, and managementstrategies[J]. APMIS, 2014, 122(6): 505-511.
[2]
Rossignol L, Vaux S, Maugat S, et al. Incidence of urinary tract infections and antibiotic resistance in the outpatient setting: a cross-sectional study[J]. Cross Mark, 2017, 45(1): 33-40.
[3]
蔡建军. 尿路感染大肠埃希菌的耐药现状调查分析[J]. 中华检验医学杂志, 2011, 21(9): 1907-1908.
[4]
周实华,秦克芝,冯艳梅,等. 尿路感染病原菌的耐药性调查分析[J]. 中华检验医学杂志, 2010, 20(1): 127-128.
[5]
Lin IJ, Chi CS, Chen CH, et al. The follow-up on thetraining coure of pediatric advanced life support[J]. Acta Paediatr Taiwan, 2000, 41(4): 205-210.
[6]
Al-Mardeni RI, Batarseh A, Omaish L. Empirical treatment for pediatric urinary tract infection and resistance patterns of uropathogens, in Queen Alia hospital and prince A'Isha military center-Jordan[J]. Saudi JKidneyDisTranspl, 2009, 20(1): 135-139.
[7]
Manges AR, Johnson JR, Foxman B, et al. Widespread distribut-ion of urinary tract infections caused by a multidrug-resistant escherichia coli clonal group[J]. N Engl J Med, 2001, 345(14): 1007-1013.
[8]
Qiao LD, Chen S, Yang Y, et al. Characteristics of urinary tract infection pathogens and their in vitro susceptibility to antimicrobial agents in China: data from a multicenter study[J]. BMJ Open, 2013, 3(12): e004152.
[9]
王剑,孟祥军,卢润文,等. 急性输尿管结石梗阻致肾感染的微创治疗[J]. 中华腔镜泌尿外科杂志(电子版), 2012, 6(3): 41-44.
[10]
El-Mahdy RH, Saleh MA, Aboelnour A, et al. GyrA mutations in nosocomial ciprofloxacin-resistant escherichia coli isolates associated with urinary tract infections[J]. Int J Curr Microbiol Appl Sci, 2017, 6(2): 1902-1907.
[11]
徐卫刚,浦裕美,裴彬,等. 老年导管伴随性尿路感染菌群分布及耐药性分析[J], 中华医院感染学杂志, 2010, 20(14): 2171-2173.
[12]
杨爱祥,吴慧娟,郑贞苍,等. 重症监护病房院内尿路感染临床分析[J]. 中华医院感染学杂志, 2009, 19(11): 1353-1355.
[13]
汪越,梁朝朝,郝宗耀,等. 上尿路结石患者尿液细菌分布的探讨[J]. 临床泌尿外科杂志, 2015, 12(30): 1092-1095.
[14]
Qiao LD, Chen S, Yang Y, et al. Characteristics of urinary tract infection pathogens and their in vitro susceptibility to antimicrobial agents in china:data from a multicenter study[J]. BMJ Open, 2013, 3: e004152.
[15]
张立. 住院患儿尿路感染病原菌的分布及耐药性分析[J]. 检验医学与临床, 2015, 12(17): 2565-2568.
[16]
Tariq R, Pardi DS, Tosh PK, et al. Fecal microbiota transplantat-ion for recurrent clostridium difficile infection reduces recurrent urinary tract infection frequency[J] Clin Infect Dis, 2017, 65(10): 1745-1747.
[1] 董红华, 郭艮春, 江磊, 吴雪飞, 马飞翔, 李海凤. 骨科康复一体化模式在踝关节骨折快速康复中的应用[J]. 中华关节外科杂志(电子版), 2023, 17(06): 802-807.
[2] 付佳, 肖海敏, 武曦, 冯涛, 师帅. 年龄校正查尔森合并症指数对腹腔镜结直肠癌围手术期并发症的预测价值[J]. 中华普通外科学文献(电子版), 2023, 17(05): 336-341.
[3] 夏松, 姚嗣会, 汪勇刚. 经腹腹膜前与疝环充填式疝修补术治疗腹股沟疝的对照研究[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(06): 702-705.
[4] 徐金林, 陈征. 抗菌药物临床应用监测对腹股沟疝修补术预防用药及感染的影响[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(06): 720-723.
[5] 代格格, 杨丽, 胡媛媛, 周文婷. 手术室综合干预在老年腹股沟疝患者中的应用效果[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(06): 759-763.
[6] 王蕾, 王少华, 牛海珍, 尹腾飞. 儿童腹股沟疝围手术期风险预警干预[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(06): 768-772.
[7] 朱青青, 卫贞祺. 腹股沟疝患者围手术期自我能效管理探讨[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(06): 773-777.
[8] 张汪, 徐淑英, 张爱华, 夏芬荣, 汪露. 手术室体温护理结合细节护理干预在老年腹股沟疝围手术期的应用效果[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(05): 635-638.
[9] 朱迪, 欧阳钒, 杨丹, 华敏, 吴倩. 双轨护理在老年腹股沟疝无张力修补术围手术期的应用[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(05): 630-634.
[10] 刘琪, 王殿琛, 符洋. 复杂腹壁疝诊疗问题与要点[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(05): 504-508.
[11] 董玉花, 魏红花, 孔荷香, 周莉, 孙小花. 主动性个性化心理干预在成人腹股沟疝围手术期患者护理中的应用[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(05): 652-656.
[12] 蓝冰, 王怀明, 王辉, 马波. 局部晚期结肠癌膀胱浸润的研究进展[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 505-511.
[13] 中华医学会骨科分会关节学组. 中国髋、膝关节置换日间手术围手术期管理专家共识[J]. 中华老年骨科与康复电子杂志, 2023, 09(06): 321-332.
[14] 苏鹏, 吕会来, 温士旺, 黄超, 张缜, 田子强. 全腔镜下食管癌根治术围手术期呼吸系统并发症发生的危险因素分析[J]. 中华消化病与影像杂志(电子版), 2023, 13(05): 294-298.
[15] 李琪, 黄钟莹, 袁平, 关振鹏. 基于某三级医院的ICU多重耐药菌医院感染影响因素的分析[J]. 中华临床医师杂志(电子版), 2023, 17(07): 777-782.
阅读次数
全文


摘要